There is no FDA-approved GHK-Cu drug product for systemic or injectable therapeutic use
The trend establishes this medicine as a preferred choice for hospital and clinic use
1,2,6,18 The recommended laboratory evaluation for patients with suspected vitamin B 12 deficiency includes a complete blood count and serum vitamin B 12 level
While semaglutide is a GLP-1 receptor agonist with a very different mechanism than TB-500, the regulatory logic applies similarly: the FDA has argued that compounding copies of patented biologics or producing peptides from unapproved bulk substances poses patient safety risks 3
For those who suffer from a vitamin B12 deficiency, injections will likely be recommended every 10 days as a build-up phase and then will continue as a monthly treatment or to be administered every 2 to 3 months in order to completely reverse the side effects of the deficiency
For chronic conditions or maintenance, 8-12 week protocols are common